As such, we found it crucial to compile a systematic review encompassing all reports of CDH1 variants described in GC patients and analyze mutation profiles and worldwide incidence with respect to implementation of HDGC clinical criteria for genetic testing. The gene discussed is CDH1; the disease is gastric cancer.